
### [NCIT:C6887](http://purl.obolibrary.org/obo/NCIT_C6887)
**Label:** Thymoma Type B1

**Subclasses:** [NCIT:C7996](http://purl.obolibrary.org/obo/NCIT_C7996) (Malignant Type B1 Thymoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C45704](http://purl.obolibrary.org/obo/NCIT_C45704) (Thymic Epithelial Cell Capable of Differentiating Towards Both Cortical and Medullary Cell Type) 52.94%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([CL:0002365](http://purl.obolibrary.org/obo/CL_0002365) (medullary thymic epithelial cell))) 41.24%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 37.51%
- [CL:0002293](http://purl.obolibrary.org/obo/CL_0002293) (epithelial cell of thymus) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 37.51%


